
Axogen rose 117.2% from $25.67 to $55.75, ahead of the S&P 500's +5.7%. Its worst day was Sep 10 (−11.5%), and its low came Nov 20 at $25.67.
Nov 20, 2025 – Nov 20, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Axogen shares rose 16.0%, while the S&P 500 rose 0.1%.
+16.0% · S&P 500 +0.1%
Story events cover the past 12 months · Times ET
EPS of $0.07 beat the $0.04 estimate on $59.9M revenue (est. $59.9M); FY revenue guidance of $265.7M against the $258.5M consensus.
−8.1% · S&P 500 +0.7%
Axogen shares rose 9.7%, while the S&P 500 rose 2.5%.
+9.7% · S&P 500 +2.5%
EPS of $0.07 beat the $-0.07 estimate on $61.5M revenue (est. $58.0M); FY revenue guidance of $270.0M against the $265.9M consensus.
+6.6% · S&P 500 −0.5%
EPS of $0.12 beat the $0.09 estimate on $69.7M revenue (est. $67.0M); FY revenue guidance of $279.0M against the $270.9M consensus.
+0.5% · S&P 500 −1.5%
At closing, $1.0 million of the estimated merger consideration will be withheld pending determination of the post-closing purchase price adjustment.
−11.5%, the year's worst day · S&P 500 −0.6%
EPS of $0.21 beat the $0.10 estimate on $75.8M revenue (est. $73.1M); FY revenue guidance of $290.0M against the $284.4M consensus.
+31.5%, the year's best day, on 9M shares, the year's heaviest volume · S&P 500 +0.3%
Axogen closed at its highest level of the year, 128.4% above where the year started.
+15.2% · S&P 500 +1.3%
Where it ended: a close of $55.75 on Nov 20, 2026. Up next: Q4 2026 earnings on Feb 23, 2027 (EPS est. $0.11, revenue est. $83.3M).
Nothing in the past 12 months.
All AXGN dividend historyReplay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for AXGN and SPY from Benzinga historical bars. Not investment advice.